Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Anterior segment tumor aspiration cutter-assisted biopsy: experience with pathology.
Milman T, Petousis V, McCormick SA, Finger PT.
Am J Ophthalmol. 2011 Nov;152(5):776-83.e1. Epub 2011 Jul 26.
Related citations
Anterior segment tumor biopsy using an aspiration cutter technique: clinical experience.
Petousis V, Finger PT, Milman T.
Am J Ophthalmol. 2011 Nov;152(5):771-5.e1. Epub 2011 Jul 27.
Effects of non-motorized voluntary running on experimental and spontaneous metastasis in mice.
Yan L, Demars LC.
Anticancer Res. 2011 Oct;31(10):3337-44.
Visualizing Bayesian analysis using a spreadsheet geometry.
Melski JW.
Arch Dermatol. 2011 Oct;147(10):1225-6. No abstract available.
Lentigo maligna: one size does not fit all.
Bowen GM, Bowen AR, Florell SR.
Arch Dermatol. 2011 Oct;147(10):1211-3. No abstract available.
Efficacy of imiquimod cream, 5%, for lentigo maligna after complete excision: a study of 43 patients.
Ly L, Kelly JW, O'Keefe R, Sutton T, Dowling JP, Swain S, Byrne M, Curr N, Wolfe R, Chamberlain A, Haskett M.
Arch Dermatol. 2011 Oct;147(10):1191-5.
Practice Gaps. Examination of genital area: comment on "Dermoscopy of pigmented lesions of the mucosa and the mucocutaneous junction".
Jaimes N, Halpern AC.
Arch Dermatol. 2011 Oct;147(10):1187-8. No abstract available.
Practice Gaps. Skin cancer detection in hair salons: opportunity knocking: comment on "Skin cancer knowledge, attitudes, and behaviors in the salon".
Mostow EN.
Arch Dermatol. 2011 Oct;147(10):1166. No abstract available.
Skin cancer knowledge, attitudes, and behaviors in the salon: a survey of working hair professionals in Houston, Texas.
Bailey EE, Marghoob AA, Orengo IF, Testa MA, White VR, Geller AC.
Arch Dermatol. 2011 Oct;147(10):1159-65.
Long-term outcome of Spitz-type melanocytic tumors.
Sepehr A, Chao E, Trefrey B, Blackford A, Duncan LM, Flotte TJ, Sober A, Mihm MC Jr, Tsao H.
Arch Dermatol. 2011 Oct;147(10):1173-9. Epub 2011 Jun 16.
Dermoscopy of pigmented lesions of the mucosa and the mucocutaneous junction: results of a multicenter study by the International Dermoscopy Society (IDS).
Blum A, Simionescu O, Argenziano G, Braun R, Cabo H, Eichhorn A, Kirchesch H, Malvehy J, Marghoob AA, Puig S, Ozdemir F, Stolz W, Tromme I, Weigert U, Wolf IH, Zalaudek I, Kittler H.
Arch Dermatol. 2011 Oct;147(10):1181-7. Epub 2011 Jun 16.
Characterization of computed tomography scan abnormalities in patients with biopsy-proven hepatic metastases from uveal melanoma.
Patel M, Winston CB, Marr BP, Carvajal RD, Schwartz GK, Wolchok J, Busam K, Abramson DH.
Arch Ophthalmol. 2011 Dec;129(12):1576-82.
CD4 T cell dependent tumor immunity stimulated by dendritic cell based vaccine.
Zhang S, Li W, Xia Z, Mao Y.
Biochem Biophys Res Commun. 2011 Sep 23;413(2):294-8. Epub 2011 Aug 27.
Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma.
Telang S, Rasku MA, Clem AL, Carter K, Klarer AC, Badger WR, Milam RA, Rai SN, Pan J, Gragg H, Clem BF, McMasters KM, Miller DM, Chesney J.
BMC Cancer. 2011 Dec 13;11:515.
Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy.
Keidar M, Walk R, Shashurin A, Srinivasan P, Sandler A, Dasgupta S, Ravi R, Guerrero-Preston R, Trink B.
Br J Cancer. 2011 Oct 25;105(9):1295-301. doi: 10.1038/bjc.2011.386. Epub 2011 Oct 6.
Birth characteristics and childhood carcinomas.
Johnson KJ, Carozza SE, Chow EJ, Fox EE, Horel S, McLaughlin CC, Mueller BA, Puumala SE, Reynolds P, Von Behren J, Spector LG.
Br J Cancer. 2011 Oct 25;105(9):1396-401. doi: 10.1038/bjc.2011.359. Epub 2011 Sep 13.
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions.
Grignol V, Fairchild ET, Zimmerer JM, Lesinski GB, Walker MJ, Magro CM, Kacher JE, Karpa VI, Clark J, Nuovo G, Lehman A, Volinia S, Agnese DM, Croce CM, Carson WE 3rd.
Br J Cancer. 2011 Sep 27;105(7):1023-9. doi: 10.1038/bjc.2011.288. Epub 2011 Aug 23.
FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines.
Kreiter S, Diken M, Selmi A, Diekmann J, Attig S, Hüsemann Y, Koslowski M, Huber C, Türeci Ö, Sahin U.
Cancer Res. 2011 Oct 1;71(19):6132-42. Epub 2011 Aug 4.
Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression.
Noman MZ, Janji B, Kaminska B, Van Moer K, Pierson S, Przanowski P, Buart S, Berchem G, Romero P, Mami-Chouaib F, Chouaib S.
Cancer Res. 2011 Sep 15;71(18):5976-86. Epub 2011 Aug 2.
Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.
Nierkens S, den Brok MH, Garcia Z, Togher S, Wagenaars J, Wassink M, Boon L, Ruers TJ, Figdor CG, Schoenberger SP, Adema GJ, Janssen EM.
Cancer Res. 2011 Oct 15;71(20):6428-37. Epub 2011 Jul 25.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on